Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant Chimpanzee Adenovirus Vaccine AdC7-M/E Protects against Zika Virus Infection and Testis Damage
Kun Xu, Yufeng Song, Lianpan Dai, et al.
Journal of Virology (2018) Vol. 92, Iss. 6
Open Access | Times Cited: 78

Showing 26-50 of 78 citing articles:

Landscape of Monoclonal Antibodies Targeting Zika and Dengue: Therapeutic Solutions and Critical Insights for Vaccine Development
Vincent Dussupt, Kayvon Modjarrad, Shelly J. Krebs
Frontiers in Immunology (2021) Vol. 11
Open Access | Times Cited: 26
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat spike protein RBD protects mice against COVID-19
Kun Xu, Yaling An, Qunlong Li, et al.
Emerging Microbes & Infections (2021) Vol. 10, Iss. 1, pp. 1574-1588
Open Access | Times Cited: 21
Human T-cell immunity against the emerging and re-emerging viruses
Min Zhao, Hangjie Zhang, Kefang Liu, et al.
Science China Life Sciences (2017) Vol. 60, Iss. 12, pp. 1307-1316
Open Access | Times Cited: 26
A Gorilla Adenovirus-Based Vaccine against Zika Virus Induces Durable Immunity and Confers Protection in Pregnancy
Ahmed O. Hassan, Igor P. Dmitriev, Elena A. Kashentseva, et al.
Cell Reports (2019) Vol. 28, Iss. 10, pp. 2634-2646.e4
Open Access | Times Cited: 25
A rapid strategy for constructing novel simian adenovirus vectors with high viral titer and expressing highly antigenic proteins applicable for vaccine development
Shengxue Luo, Panli Zhang, Xiaorui Ma, et al.
Virus Research (2019) Vol. 268, pp. 1-10
Closed Access | Times Cited: 24
The Cellular Impact of the ZIKA Virus on Male Reproductive Tract Immunology and Physiology
Raquel Almeida, Heloísa Antoniella Braz-de-Melo, Igor de Oliveira Santos, et al.
Cells (2020) Vol. 9, Iss. 4, pp. 1006-1006
Open Access | Times Cited: 23
S100A4+ macrophages facilitate zika virus invasion and persistence in the seminiferous tubules via interferon-gamma mediation
Wei Yang, Yanhua Wu, Shuangqing Liu, et al.
PLoS Pathogens (2020) Vol. 16, Iss. 12, pp. e1009019-e1009019
Open Access | Times Cited: 21
Increased growth ability and pathogenicity of American- and Pacific-subtype Zika virus (ZIKV) strains compared with a Southeast Asian-subtype ZIKV strain
Yasuhiro Kawai, Eri Nakayama, Kenta Takahashi, et al.
PLoS neglected tropical diseases (2019) Vol. 13, Iss. 6, pp. e0007387-e0007387
Open Access | Times Cited: 20
Characterization of a Species E Adenovirus Vector as a Zika virus vaccine
Brianna L. Bullard, Brigette N. Corder, David N. Gordon, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 19
Cross-Reactive Antibodies during Zika Virus Infection: Protection, Pathogenesis, and Placental Seeding
Matthew G. Zimmerman, Jens Wrammert, Mehul S. Suthar
Cell Host & Microbe (2020) Vol. 27, Iss. 1, pp. 14-24
Open Access | Times Cited: 18
SARS-CoV-2 virus: Vaccines in development
Qingrui Huang, Jinghua Yan
Fundamental Research (2021) Vol. 1, Iss. 2, pp. 131-138
Open Access | Times Cited: 17
Adenovirus vector-based vaccines as forefront approaches in fighting the battle against flaviviruses
M Mahmoudian Shoushtari, Farzin Roohvand, Mostafa Salehi‐Vaziri, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 5
Open Access | Times Cited: 12
An effective live-attenuated Zika vaccine candidate with a modified 5′ untranslated region
Farzana Nazneen, E. Ashley Thompson, Claire Blackwell, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 6
Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates
Ying Zhan, Yao Deng, Baoying Huang, et al.
Vaccine (2019) Vol. 37, Iss. 15, pp. 2122-2130
Open Access | Times Cited: 18
Divergent Peptide Presentations of HLA-A*30 Alleles Revealed by Structures With Pathogen Peptides
Shiyan Zhu, Kefang Liu, Yan Chai, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 17
Therapeutic Advances Against ZIKV: A Quick Response, a Long Way to Go
Juan‐Carlos Sáiz
Pharmaceuticals (2019) Vol. 12, Iss. 3, pp. 127-127
Open Access | Times Cited: 17
Nonhuman Adenoviral Vector-Based Platforms and Their Utility in Designing Next Generation of Vaccines for Infectious Diseases
Marwa Alhashimi, Ahmed Elkashif, Ekramy E. Sayedahmed, et al.
Viruses (2021) Vol. 13, Iss. 8, pp. 1493-1493
Open Access | Times Cited: 14
Isolation of novel simian adenoviruses from macaques for development of a vector for human gene therapy and vaccines
Wendong Lan, Lulu Quan, Yiqiang Li, et al.
Journal of Virology (2023) Vol. 97, Iss. 10
Open Access | Times Cited: 5
A high infectious simian adenovirus type 23 vector based vaccine efficiently protects common marmosets against Zika virus infection
Shengxue Luo, Wei Zhao, Xiaorui Ma, et al.
PLoS neglected tropical diseases (2020) Vol. 14, Iss. 2, pp. e0008027-e0008027
Open Access | Times Cited: 14
Zika virus—an update on the current efforts for vaccine development
Victória Alves Santos Lunardelli, Juliana de Souza Apostólico, Edgar Ruz Fernandes, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 17, Iss. 3, pp. 904-908
Open Access | Times Cited: 14
Long-Term Protection of Rhesus Macaques from Zika Virus Reinfection
Gage K. Moreno, Christina M. Newman, Michelle R. Koenig, et al.
Journal of Virology (2019) Vol. 94, Iss. 5
Open Access | Times Cited: 13
Next generation agents (synthetic agents): Emerging threats and challenges in detection, protection, and decontamination
Anshula Sharma, Gaganjot Gupta, Tawseef Ahmad, et al.
Elsevier eBooks (2019), pp. 217-256
Closed Access | Times Cited: 12
A tandem-repeat dimeric RBD protein-based COVID-19 vaccine ZF2001 protects mice and nonhuman primates
Yaling An, Shihua Li, Xiyue Jin, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
A Vesicular Stomatitis Virus-Based Vaccine Carrying Zika Virus Capsid Protein Protects Mice from Viral Infection
Xiaodan Shi, Jingping Hu, Jing Guo, et al.
Virologica Sinica (2019) Vol. 34, Iss. 1, pp. 106-110
Open Access | Times Cited: 11
Pre-Clinical Pregnancy Models for Evaluating Zika Vaccines
In-Jeong Kim, Marcia A. Blackman, Jr‐Shiuan Lin
Tropical Medicine and Infectious Disease (2019) Vol. 4, Iss. 2, pp. 58-58
Open Access | Times Cited: 10

Scroll to top